PNC Financial Services Group
LUCD icon

PNC Financial Services Group’s Lucid Diagnostics LUCD Stock Holding History

PNC Financial Services Group’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$202 Buy
176
+6
+4% +$8 ﹤0.01% 5031
2025
Q4 		$185 Buy
+170
New +$190 ﹤0.01% 4988

Other funds holding LUCD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

PNC Financial Services Group's LUCD Position: Q1 2026 in Review

PNC Financial Services Group increased its Lucid Diagnostics (LUCD) stake by 3.5% in Q1 2026, buying an estimated $8 and bringing the position to 176 shares worth $202. The position accounts for ﹤0.01% of the portfolio, ranked #5031.

PNC Financial Services Group first reported a position in LUCD in Q4 2025 and has held it in 2 quarters since. 103 funds tracked by Wall St. Rank hold LUCD as of Q1 2026.

  • PNC Financial Services Group held 176 shares of Lucid Diagnostics worth $202 as of Q1 2026.
  • PNC Financial Services Group bought 6 Lucid Diagnostics shares in Q1 2026, an estimated $8.
  • Lucid Diagnostics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #5031 holding.
  • PNC Financial Services Group first reported a position in Lucid Diagnostics in Q4 2025 and has held it in 2 quarters since.
  • 103 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.